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Acute kidney injuryBackground: Potassium dichromate induces nephrotoxicity mainly due to increased cellular oxidative
stress.
Objectives: To evaluate the possible renoprotective effects of eugenol on the damage induced by potas-
sium dichromate poisoning in male rats.
Methods: 30 male Wistar rats were divided into 3 groups, 10 rats in each group; Control group: given
olive oil orally (5 mL/kg body weight) for 10 consecutive days. Potassium dichromate (PDC) group:
received olive oil orally (5 mL/kg body weight) for 10 consecutive days, then a single s.c. injection of
PDC (15 mg/kg) was given in the tenth day. And eugenol + PDC group: received eugenol orally (100
mg/kg body weight/day) for 10 consecutive days and a single s.c. injection of PDC (15 mg/kg) in the tenth
day.
Then the animals were anaesthetized, blood samples were taken from the abdominal aorta, for mea-
surement of serum urea and creatinine, and lactate dehydrogenase (LDH). Also reduced glutathione
(GSH), malondialdehyde (MDA), superoxide dismutase (SOD) and tumor necrosis factor alpha (TNF-a)
were monitored in renal tissue.
Results: PDC caused significant increase in serum urea, creatinine and LDH levels; this was accompanied
with significant decrease in renal GSH and SOD contents, and increase in renal MDA and TNF-a.
Histopathological investigations provoked tubular necrosis associated with mononuclear cell infiltration.
Pretreatment of rats with eugenol significantly change all previously mentioned PDC-induced effects.
Conclusion: The findings of the current study revealed that eugenol protected the kidney against PDC-
induced acute kidney injury in rats by its antioxidant and anti-inflammatory properties.
 2018 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chromium (Cr) is a heavy metal that has several valence states;
the most common one is the hexavalent chromium (CrVI), that is
widely used in industries, e.g. leather tanning, stainless steel man-
ufacturing, chrome plating (chromates added as anticorrosive
agents to paints, primers, and other surface coatings), welding
and wood preservation.1,2 CrVI can also be found in drinking water
and in public water systems.3 Environmental and/or occupational
exposure to CrVI-containing compounds is known to be toxic and
carcinogenic to human beings and animals.4 A major adverse effect
of chromium poisoning is nephrotoxicity due to chromium excre-
tion through the kidney, this increases its chromium content and
subsequently, nephropathy occurs.5 The toxic manifestations ofchromium are considered to be due to oxidative stress.6,7 leading
to serious damage to the vital organs.8,9
Potassium dichromate is used to induce oxidative kidney dam-
age.10 Nephrotoxicity induced by PDC in rat mimics the occupa-
tional hazard.11
Eugenol (1-allyl-4-hydroxy-3-methoxybenzene, C10H12O2) is a
naturally occurring substance, extracted from certain essential oils
especially clove oil as well as nutmeg, cinnamon, and basil oils.12,13
It has many pharmacological properties such as antioxidant, anal-
gesic, anti-inflammatory, and antipyretic actions,12,14 while it has
been shown to ameliorate kidney injury in streptozotocin-
induced diabetic rats,15 and in gentamycin induced nephrotoxic-
ity,16 but its effect on PDC induced nephrotoxicity has not been
investigated yet. So, this study aimed to assess the possible protec-
tive effect of eugenol, in a PDC induced acute kidney injury rat
model.
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2.1. Animals
This study was conducted on 30 male Wistar rats, weighing
200–220 g. purchased from the Experimental Animal House of Fac-
ulty of Science, Tanta University. The rats were kept in plastic cages
(5 rats per cage) under controlled environmental conditions, 12/12
h light/dark cycle, at room temperature (23 ± 2 C), with free access
towater and food. All protocols were approved by the Tanta Univer-
sity ethical committee, (code approval number: 40118/08/29).2.2. Chemicals
In this study, eugenol and PDC were purchased from Sigma-
Aldrich (USA). They were diluted and dissolved in olive oil and sal-
ine (0.9%) respectively for administration.2.3. Study design
Rats were divided into 3 groups, 10 rats per each group.
Control group: Rats were gavaged with olive oil (5 mL/kg body
weight/day) for 10 consecutive days.
PDC group: Rats were daily gavaged with olive oil, like control
group, then intoxicated in the tenth day with a single s.c. injection
of PDC (15 mg/kg) freshly dissolved in saline.17
Eugenol (Eu) + PDC group: Rats received eugenol orally (100
mg/kg body weight/day) for 10 consecutive days,16 and a single s.
c. injection of PDC (15 mg/kg) in the tenth day.17
The doses of eugenol and PDC employed were the effective
doses that used in previous researches.
Twenty-four hours after the last treatment, rats in all groups
were anaesthetized with ketamine (75 mg/kg). Midline laparotomy
was performed. Blood samples were taken from the abdominal
aorta, then serum was separated by centrifugation (3000 rpm for
10 min) for the immediate analysis of urea and creatinine, and ali-
quot was then stored until further analysis.
Also the kidneys were immediately dissected out for
histopathological evaluation, and biochemical analysis of renal tis-
sue. Finally, the rats were sacrificed by decapitation under general
anesthesia.2.4. Estimation of renal function biomarkers
Serum urea and creatinine were determined colorimetric,
according to Bauer et al.18 method.2.5. Estimation of renal tissue damage marker in serum
Serum lactate dehydrogenase (LDH) was estimated colorimet-
ric, according to Sharma, and Datta19 method.2.6. Estimation of oxidative stress markers in kidney
Weighed parts from both kidneys were homogenized in ice-
cold 0.1 M sodium phosphate buffer (pH 7.4) to prepare a 10%
(w/v) tissue homogenate. The homogenate was centrifuged for
30 min at 4000 rpm at 4 C. The resultant supernatant was used
to measure reduced glutathione (GSH), malondialdehyde (MDA)
and superoxide dismutase (SOD), using GSH, MDA and SOD assay
kits, according to the methods described by Akerboom and Sies,20
Janero,21 and Kuthan et al.22 respectively.2.7. Estimation of inflammatory biomarker in kidney
Tumor necrosis factor alpha (TNF-a) was determined in the kid-
ney using TNF-a ELISA kit (obtained from Sigma chemical Co.),
according to Navarro et al.23 method.
2.8. Histopathological analysis
Parts of kidneys from all groups were fixed in 10% buffered for-
malin for 72 h. at room temperature then washed under running
water, dehydrated in ascending concentrations of ethanol, cleared
in xylene and finally, embedded in paraffin. Then sections of 5 lm
thickness were stained with hematoxylin and eosin and evaluated
by light microscopy.24
2.9. Statistical calculations
Collected data were statistically analyzed by one–way ANOVA,
followed by Tukey test, to determine statistical significance
between different groups using SPSS software package 23.0. Data
was presented as mean ± SD, and P < 0.05 was considered statisti-
cally significant.3. Results
3.1. Effect of eugenol on kidney function and serum LDH
A significant elevation in serum urea, creatinine and LDH levels
was observed in PDC group compared with those of control group.
Pretreatment with eugenol, significantly decreased their levels
when compared with PDC group, but still significantly elevated
when compared with those of control group (Fig. 1).
3.2. Effect of eugenol on kidney oxidative stress markers
Renal GSH and SOD levels were significantly reduced, while a
significant elevation of renal MDA content was detected following
PDC administration. Treatment of rats with eugenol, prior to PDC
injection significantly elevated GSH and SOD levels, with normal-
ization of SOD level, while GSH level still significantly lower than
normal control values. Also, MDA level was significantly reduced
after pretreatment with eugenol, and still significantly higher than
normal control values (Fig. 2).
3.3. Effect of eugenol on renal inflammatory biomarker
PDC injection significantly increased renal TNF-a level, com-
pared to the control group. The rats treated with eugenol showed
a significant decrease in renal TNF-a level compared to the PDC
group, but its level still significantly higher compared to the con-
trol group (Fig. 2).
3.4. Histopathological observations
The kidney sections from the rats of control groups showed nor-
mal histological structures with normal glomeruli and renal
tubules (Fig. 3a), PDC caused histopathological alterations in the
form of diffuse coagulative necrosis in most of the renal tubules,
congestion of interstitial blood vessel, associated with fibroblastic
proliferation and mononuclear cell infiltration (Fig. 3b, c). These
alterations were markedly reduced in Eu + PDC group as renal
tubules showed mild tubular damage and very mild inflammatory
cell infiltrates in addition to few regenerative renal tubules
(Fig. 3d).
Fig. 1. Serum levels of urea (A), creatinine (B), and LDH (C) in all groups. aP < 0.05 vs group I. bP < 0.05 vs group II.
Fig. 2. Tissue levels of MDA (A), GSH (B), SOD (C), and TNF-a (D) in all groups. aP < 0.05 vs group I. bP < 0.05 vs group II.
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Potassium dichromate was used to induce oxidative kidney
damage.10 The kidneys were considered to be the target organsof systemically absorbed chromate, and nephrotoxicity could be
the primary cause of death in cases of acute chrome exposure.5
The massive reactive oxygen species production was considered
to be the cause of toxic effect of PDC, and has been attributed to
(A) (B)
(C) (D)
Fig. 3. Kidney histopathology (X400). (A) Control group: normal histological structure of the glomeruli and tubules. (B) PDC group: congestion of interstitial blood vessel,
diffuse coagulative necrosis in most of the renal tubules and mononuclear cell infiltration. (C) PDC group: fibroblastic proliferation and mononuclear cell infiltration (D) Eu +
PDC group: focal necrosis of epithelial lining associated with uniformly arranged regenerative renal tubules.
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induces damage of cellular components.25 The tubular damage
and nephrotoxic effect of chromate resulted from its accumulation
in vacuoles inside the cells of proximal convoluted tubules that
lead to slow excretion and remaining of Cr in the kidney for a long
time.26
In the present study, injection of a single dose of PDC, induced
acute kidney injury in rats as evidenced by the significant alter-
ation of the serum levels of urea, creatinine and LDH and con-
firmed with the severe changes in histopathology of PDC group,
particularly tubular necrosis. These results are denoting the
nephrotoxic effect of PDC, and are in accordance with those
reported by Salama et al.,10 Arreola-Mendoza et al.,27 and Yam-
Canul et al.28
This nephrotoxic effect of PDC could be attributed to the PDC
induced oxidative stress, as evidenced by increased level of MDA
and decreased levels GSH and SOD in the kidney tissues of PDC
group. Another mechanism of nephrotoxic effect of PDC may be
increased inflammatory process as evidenced by significant
increase of the renal TNF-a level after PDC injection, and confirmed
by histopathological findings especially, mononuclear cell infiltra-
tion, but this increased inflammatory process may be promoted by
oxidative injury of the renal tissues itself.29 These findings are in
accordance with many other studies.10,27 Also, Beaver et al.30
reported induction of acute inflammatory reaction with neu-
trophils, macrophages, and lymphocytic cell infiltration induced
by chromium.
In this study, pretreatment of rat with eugenol markedly pro-
tected the kidney against PDC-induced AKI and oxidative stress,
as evidenced by the significant decrease in serum levels of urea,
creatinine and LDH and improvement of histopathological changes
occurred in PDC group as well as significant changes in renal con-
tents of MDA, GSH and SOD. The anti-inflammatory effect of euge-
nol was confirmed by the significant decrease of TNF-a and by the
histopathological findings that showed marked improvements ofrenal tissues with mild degenerative changes in the epithelial lin-
ing of renal tubules with no evidence of interstitial inflammatory
cell infiltrate in rats treated by eugenol.
The antioxidative potential of eugenol has been studied in a
number of studies where it has been shown to bind to free oxygen
radicals and attenuate the action of oxidative substances.16,31–33
Also, the anti-inflammatory effects of Eugenol has been
described by Huss et al.,34 it was also reported that eugenol acts
as an anti-inflammatory substance35 and reducing the release of
proinflammatory mediators such as TNF-a, and PGE2.36,37
5. Conclusion
The present study confirmed that eugenol offers protection
against PDC-induced AKI in rats by its direct antioxidant effect
and by lowering the production of inflammatory mediators such
as TNF-a.
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